The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Grup (Q54123667)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Grup |
scientific article |
Statements
The influence of HLA-matched sibling donor availability on treatment outcome for patients with AML: an analysis of the AML 8A study of the EORTC Leukaemia Cooperative Group and GIMEMA. European Organization for Research and Treatment of Cancer. Grup (English)
Keating S
de Witte T
Suciu S
Willemze R
Hayat M
Labar B
Resegotti L
Ferrini PR
Caronia F
Dardenne M
Solbu G
Petti MC
Vegna ML
Mandelli F
Zittoun RA
1 September 1998
102
5
1344-1353
1 reference
1 reference
1 reference